{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:51:24Z","timestamp":1784605884953,"version":"3.55.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:00:00Z","timestamp":1604102400000},"content-version":"am","delay-in-days":396,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.arcped.2019.09.006","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T08:20:34Z","timestamp":1571300434000},"page":"419-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Severe hyperhomocysteinemia and peripheral neuropathy as side effects of nitrous oxide in two patients with sickle cell disease"],"prefix":"10.1016","volume":"26","author":[{"given":"J.","family":"Neveu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Perelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Suisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Monpoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2019.09.006_bib0070","doi-asserted-by":"crossref","unstructured":"[No authors listed]. Guideline statement: management of procedure-related pain in children and adolescents. J Paediatr Child Health 2006;42 Suppl 1:1-29.","DOI":"10.1111\/j.1440-1754.2006.00798_2.x"},{"key":"10.1016\/j.arcped.2019.09.006_bib0075","doi-asserted-by":"crossref","first-page":"e548","DOI":"10.1111\/apa.12773","article-title":"How French paediatric emergency departments manage painful vaso-occlusive episodes in sickle cell disease patients","volume":"103","author":"Galeotti","year":"2014","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.arcped.2019.09.006_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2010.10.033","article-title":"Nitrous oxide-induced B12 deficiency myelopathy: Perspectives on the clinical biochemistry of vitamin B12","volume":"301","author":"Hathout","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.arcped.2019.09.006_bib0085","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0140-6736(01)06575-8","article-title":"Adverse events of premixed nitrous oxide and oxygen for procedural sedation in children","volume":"358","author":"Gall","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2019.09.006_bib0090","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0140-6736(78)92101-3","article-title":"Myeloneuropathy after prolonged exposure to nitrous oxide","volume":"2","author":"Layzer","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2019.09.006_bib0095","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1016\/j.clinph.2016.08.005","article-title":"Clinical and electrodiagnostic characteristics of nitrous oxide-induced neuropathy in Taiwan","volume":"127","author":"Li","year":"2016","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.arcped.2019.09.006_bib0100","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jemermed.2010.04.020","article-title":"Severe myeloneuropathy from acute high-dose nitrous oxide (N2O) abuse","volume":"41","author":"Alt","year":"2011","journal-title":"J Emerg Med"},{"key":"10.1016\/j.arcped.2019.09.006_bib0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/mus.880140105","article-title":"Reversible myeloneuropathy of nitrous oxide abuse: serial electrophysiological studies","volume":"14","author":"Vishnubhakat","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.arcped.2019.09.006_bib0110","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/mus.24482","article-title":"Severe motor neuropathy or neuronopathy due to nitrous oxide toxicity after correction of vitamin B12 deficiency","volume":"51","author":"Morris","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.arcped.2019.09.006_bib0115","first-page":"43","article-title":"Myeloneuropathy from nitrous oxide abuse: unusually high methylmalonic acid and homocysteine levels","volume":"102","author":"Waclawik","year":"2003","journal-title":"WMJ"},{"key":"10.1016\/j.arcped.2019.09.006_bib0120","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2257.1999.00261.x","article-title":"Sickle cell disease and nitrous oxide-induced neuropathy","volume":"21","author":"Ogundipe","year":"1999","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.arcped.2019.09.006_bib0125","first-page":"473","article-title":"Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy","volume":"114","author":"Ueland","year":"1989","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.arcped.2019.09.006_bib0130","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jama.2011.235","article-title":"Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: A randomized clinical trial","volume":"305","author":"Gladwin","year":"2011","journal-title":"JAMA"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X19301435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X19301435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:52:32Z","timestamp":1760539952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X19301435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0929693X19301435"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2019.09.006","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe hyperhomocysteinemia and peripheral neuropathy as side effects of nitrous oxide in two patients with sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2019.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}